4-((2-amino-4-hydroxy-6-pteridylmethyl)amino)benzoic acid,
p-((2-amino-4-hydroxy-6-pteridylmethyl)amino)benzoic acid,
pteroic acid,
Pteroic acid,
119-24-4,
4-(((2-Amino-4-oxo-3,4-dihydropteridin-6-yl)methyl)amino)benzoic acid,
NSC 14972,
4-{[(2-amino-4-hydroxypteridin-6-yl)methyl]amino}benzoic acid,
UNII-8258W48TBZ,
4-((2-Amino-4-hydroxy-6-pteridylmethyl)amino)benzoic acid,
p-((2-Amino-4-hydroxy-6-pteridylmethyl)amino)benzoic acid,
p-[(2-amino-4-hydroxy-6-pteridylmethyl)amino]benzoic acid,
CHEMBL341824,
CHEBI:27623,
JOAQINSXLLMRCV-UHFFFAOYSA-N,
8258W48TBZ,
4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoic acid,
PT1,
4-[[(2-Amino-3,4-dihydro-4-oxo-6-pteridinyl)methyl]amino]benzoic Acid,
Pterotic Acid,
Peroic Acid,
4-{[(2-amino-4-oxo-3,4-dihydropteridin-6-yl)methyl]amino}benzoic acid,
78H,
Pteridine deriv. 12,
Pteroic acid (8CI),
1br6,
Pteroic acid, >=93%,
AC1L3TH3,
AC1Q5TY1,
SCHEMBL245980,
BDBM6645,
CHEBI:37055,
CHEBI:37066,
CTK8F0692,
KS-00000GZR,
DTXSID40152279,
BCP04836,
CS-M2878,
EX-A2652,
NSC14972,
ZINC6628789,
ZX-AT015845,
3247AH,
EBD232548,
MFCD00075823,
NSC-14972,
AKOS015995562,
AKOS016009238,
API0008566,
DB04196,
DS-3903,
MP-0724,
OR17919,
4CA-1054,
AJ-70432,
AK108340,
DA-16638,
SC-62878,
AB0033448,
AB0068684,
AB0109902,
AM20120647,
FT-0674151,
ST24028705,
X7000,
C07582,
C-54629,
SR-01000883746,
J-004089,
SR-01000883746-1,
Benzoic acid,4-dihydro-4-oxo-6-pteridinyl)methyl]amino]-,
4-((2-amino-4-hydroxypteridin-6-yl)methylamino)benzoic acid,
p-((2-amino-4-hydroxypteridin-6-yl)methylamino)benzoic acid,
4-([(2-Amino-4-oxo-3,4-dihydro-6-pteridinyl)methyl]amino)benzoic acid #,
4-[(2-Amino-4-oxo-3,4-dihydropteridin-6-ylmethyl)-amino]-benzoic acid,
4-{[(2-amino-3,4-dihydro-4-oxopteridin-6-yl)methyl]amino}benzoic acid,
4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}benzoic acid,
Benzoic acid, 4-(((2-amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)-,
Benzoic acid, p-[[(2-amino-3,4-dihydro-4-oxo-6-pteridinyl)methyl]amino]-,
Folic acid impurity D, European Pharmacopoeia (EP) Reference Standard,
4-[[(2-Amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino]benzoic Acid (Pteroic Acid),
Benzoic acid, 4-(((2-amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)- (9CI),
Folic Acid Impurity D, Pharmaceutical Secondary Standard; Certified Reference Material,
Pyrofolic acid,
7,8-dihydropteroate,
D03GJB,
C14H12N6O3,
CID95054,
AR-1K9609,
C14-H12-N6-O3,
ACN-038339,
CS-O-11076,
4-(((2-Amino-4-oxo-3,4-dihydropteridin-6-yl)methyl)amino)benzoicacid,
4-[[(2-amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl]amino]benzoic acid,
2-AMINO-6-[(4-CARBOXY-PHENYLAMINO)-METHYL]-4-HYDROXY-PTERIDIN-1-IUM,
4955-72-0,
5-(3-(benzyloxy)phenyl)-7-((1r,3r)-3-(pyrrolidin-1-ylmethyl)cyclobutyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine,
71265-68-4,
APT,